Related Experiment Video
Updated: May 29, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Skin manifestations of obesity: a comparative study
J C Boza1, E N Trindade, J Peruzzo
1Department of Dermatology, Federal University of Rio Grande do Sul (UFRGS), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. juliana_boza@yahoo.com.br
Journal of the European Academy of Dermatology and Venereology : JEADV
|September 21, 2011
Summary
Obesity is linked to numerous skin conditions, including striae and infections. Early detection and management of these skin issues are crucial for improving the quality of life for obese individuals.
Area of Science:
- Dermatology
- Endocrinology
- Public Health
Background:
- Obesity is a global health crisis with limited research on associated skin diseases.
- Skin manifestations in obese individuals require further investigation.
Purpose of the Study:
- To determine the prevalence of skin conditions in obese patients compared to normal-weight individuals.
- To identify specific dermatoses associated with obesity.
Main Methods:
- A comparative study included 76 obese patients (BMI ≥30 kg/m²) and 73 normal-weight controls (BMI 18.5-24.9 kg/m²).
- Comprehensive medical history and skin examinations were conducted by a single examiner.
- All participants were screened for metabolic syndrome.
Main Results:
- Obesity was significantly associated with striae, plantar hyperkeratosis, acrochordons, intertrigo, pseudoacanthosis nigricans, keratosis pilaris, lymphedema, and bacterial infections.
- Striae, pseudoacanthosis nigricans, and bacterial infections showed a correlation with the degree of obesity.
Conclusions:
- Obesity is strongly associated with various skin alterations that can serve as indicators of excessive weight.
- Specialized dermatological care for obese patients is essential due to the high prevalence of these conditions.
- Many obesity-related skin disorders are preventable and treatable, offering potential improvements in patient quality of life.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:02Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
01:14Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...